PHARMACOTHERAPY OF PULMONARY HYPERTENSION DURING PREGNANCY AND POSTPARTUM PERIOD

Cover Page


Cite item

Full Text

Abstract

Pregnancy in women with pulmonary hypertension is associated with a high risk of poor outcomes and high maternal mortality rates, therefore contraindicated in this category of patients. Yet the world has accumulated some experience of pregnancy in women with pulmonary hypertension, who refused abortion, or in whom the disease was diagnosed in later stages of gestation. In this paper results of randomized and observational studies of the main and supportive pharmacotherapy in pulmonary hypertension are given, characteristics of modern drugs for the treatment of pulmonary hypertension and data on their safety during pregnancy are recommended, as well as expert opinion on drug therapy in pregnant women with pulmonary hypertension.

Full Text

ФАРМАКОТЕРАПИЯ ЛЕГОЧНОЙ ГИПЕРТЕНЗИИ ВО ВРЕМЯ БЕРЕМЕННОСТИ И В ПОСЛЕРОДОВОМ ПЕРИОДЕ
×

References

  1. Role of combination therapy in the treatment of pulmonary arterial hypertension / T. Abraham [et al.] // Pharmacotherapy. - 2010. - Vol. 30, №4. - Р. 390-404.
  2. Bedard E. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? / E. Bedard, K. Dimopoulos, M.A. Gatzoulis // Eur Heart J. - 2009. - Vol. 30, №3. - Р. 256-265.
  3. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases / M. Bonnin [et al.] // Anesthesiology. - 2005. - Vol. 102, №6. - Р. 1133-1137.
  4. Borges V.T. Eisenmenger syndrome in pregnancy / V.T. Borges, C.G. Magalhaes, A.M. Martins // Arq Bras Cardiol. - 2008. - Vol. 90, № 5. - Р. 39-40.
  5. Cheek T.G. Maternal physiologic alteration during pregnancy / T.G. Cheek, B.B. Gutsche // Shnider and Levinson's Anesthesia for Obstetrics / eds.: S.C. Hugues, G. Levinson, M.A. Rosen. - Philadelphia: Lippincott Williams & Wilkins, 2001. - P. 3-18.
  6. Pulmonary arterial hypertension: Advances in pathophysiology and management / S. Chopra [et al.] // Indian J Pharmacol. -2012. - Vol. 44, № 1. - Р. 4-11.
  7. Risk of warfarin during pregnancy with mechanical valve prostheses / M. Cotrufo [et al.] // Obstet Gynecol. - 2002. - Vol. 99. - Р. 35-40.
  8. Fukumoto Y. Recent progress in the management of pulmonary hypertension / Y. Fukumoto, H. Shimokawa // Circ J. - 2011. - Vol. 75, № 8. - Р. 1801-1810.
  9. Primary pulmonary hypertension: Natural history and the importance of thrombosis / V. Fuster [et al.] // Circulation. - 1984. - Vol. 70. - Р. 580-587.
  10. Sildenafil citrate therapy for pulmonary arterial hypertension / N. Galie [et al.] // N Engl J Med. - 2005. - Vol. 353. -Р. 2148-2157.
  11. Guidelines for the diagnosis and treatment of pulmonary hypertension / N. Galie [et al.] // Eur Heart J. - 2009. -Vol. 30. - Р. 2493-2537.
  12. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension / S. Goland [et al.] // Cardiology. - 2010. - Vol. 115, №3. - Р. 205-208.
  13. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy / T.M. Goodwin [et al.] // Am J Obstet Gynecol. - 1999. - Vol. 180, №1 (Pt 1). - Р. 64-67.
  14. Meta-analysis of randomized controlled trials on treatment of pulmonary arterial hypertension / B. He [et al.] // Circ J. -2010. - Vol. 74, № 7. - Р. 1458-1464.
  15. Hsu C.H. The management of pregnancy and pregnancy-related medical conditions in pulmonary arterial hypertension patients / C.H. Hsu, M. Gomberg-Maitland, C. Glassner // Int J Clin Pract. - 2011. -Vol. 65 (Suppl. 172). - Р. 6-14.
  16. Huang S. Treatment of pulmonary arterial hypertension in pregnancy / S. Huang, Hermes DeSantis, R. Evelyn // Am J Health Syst Pharm. - 2007. - Vol. 64. -Р. 1922-1926.
  17. Ivy D.D. Prostacyclin in the intensive care setting / D.D. Ivy // Pediatr Crit Care Med. - 2010. - Vol. 11, № 2 (Suppl.). -Р. S41-S45.
  18. Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension / D.D. Ivy [et al.] // J Am Coll Cardiol. - 2008. - Vol. 51, № 2. - Р. 161-169.
  19. Kiely D.G. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach / D.G. Kiely, R. Condliffe, V. Webster // BJOG. - 2010. - Vol. 117. - Р. 565-574.
  20. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy / G.K. Lam [et al.] // Obstet Gynecol. - 2001. -Vol. 98, № 5 (Pt 2). - Р. 895-898.
  21. ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American. Heart Association Developed in Collaboration With the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association / V.V. McLaughlin [et al.] // J Am Coll Cardiol. - 2009. - Vol. 53, № 17. - Р. 1573-1619.
  22. Eisenmenger's syndrome in a 27 week pregnancy - management with bosentan and sildenafil / V. Molelekwa [et al.] // Ir Med J. - 2005. - Vol. 98. - Р. 87-88.
  23. Monnery L. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators / L. Monnery, J. Nanson, G. Charlton // Br J Anaesth. - 2001. - Vol. 87, № 2. - Р. 295-298.
  24. Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension / D. Montani [et al.] // Eur Heart J. - 2010. - Vol. 31, № 15. -Р. 1898-1907.
  25. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach / D. Mukeijee [et al.] // Ann Rheum Dis. - 2003. - Vol. 62. - Р. 1088-1093.
  26. Ng W.P. Successful maternal-foetal outcome using nitric oxide and sildenafil in pulmonary hypertension with atrial septal defect and HIV infection / W.P. Ng, W.L. Yip // Singapore Med J. - 2012. - Vol. 53, № 1. - Р. 3-5.
  27. Long-term therapy with inhaled iloprost in patients with pulmonary hypertension / H. Olschewski [et al.] // Respir Med. -2010. - Vol. 104, № 5. - Р. 731-740.
  28. Pfizer. Pfizer stops clinical trials of Thelin and initiates voluntary product withdrawal in the interest of patient safety [press release]. - December 10, 2010.
  29. ESC guidelines on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology / V. Regitz-Zagrosek [et al.] // Eur Heart J. - 2011. - Vol. 32, №24. - Р. 3147-3197.
  30. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension / J.N. Robinson [et al.] // Am J Obstet Gynecol. - 1999. - Vol. 180, № 4. -Р. 1045-1046.
  31. Rubin L.J. Primary pulmonary hypertension / L.J. Rubin // Chest. - 1993. -Vol. 104. - Р. 236-250.
  32. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study / L.J. Rubin [et al.] // Chest. - 2011. - Vol. 140, № 5. -Р. 1274-1283.
  33. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival / O. Sitbon [et al.] // J Am Coll Cardiol. - 2002. - Vol. 40. - Р. 780-788.
  34. Pregnancy and primary pulmonary hypertension: Successful outcome with epoprostenol therapy / R. Stewart [et al.] // Chest. - 2001. - Vol. 119. - Р. 973-975.
  35. Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report / M. Streit [et al.] // J Med Case Reports. - 2009. - Vol. 3. - Р. 7255.
  36. Stringham R. Pulmonary arterial hypertension: an update on diagnosis and treatment / R. Stringham, N.R. Shah // Am Fam Physician. - 2010. - Vol. 82, № 4. - Р. 370-377.
  37. Tonelli A.R. Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension / A.R. Tonelli, H. Alnuaimat, K. Mubarak // Respir Med. -2010. - Vol. 104, № 4. - Р. 481-496.
  38. Weiss B.M. Pulmonary vascular disease and pregnancy: Current controversies, management strategies, and perspectives / B.M. Weiss, O.M. Hess // Eur Heart J. -2000. - Vol. 21. - Р. 104-115.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Ushkalova E.A., Runihina N.K., Novikova I.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies